Drug resistance is not directly affected by mating type locus zygosity in Candida albicans

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1207-1212

  Pujol, Claude ^a   Messer, Shawn A ^b   Pfaller, Michael ^b   Soll, David R ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL BUDDING; DNA FINGERPRINTING; DRUG EFFECT; FUNGUS ISOLATION; GENE LOCUS; GENETIC HETEROGENEITY; GENETIC LINKAGE; MATING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; ZYGOSITY;

CANDIDA ALBICANS; CHROMOSOME MAPPING; DRUG RESISTANCE, FUNGAL; GENES, FUNGAL; GENES, MATING TYPE, FUNGAL; MICROBIAL SENSITIVITY TESTS;

EID: 0037378010     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1207-1212.2003     Document Type: Article

References (39)

1. Anderson, J., T. Srikantha, B. Morrow, S. H. Miyasaki, T. C. White, N. Agabian, J. Schmid, and D. R. Soll. 1993. Characterization and partial nucleotide sequence of the DNA fingerprinting probe Ca3 of Candida albicans. J. Clin. Microbiol. 31:1472-1480.
2. Balan, I., A. M. Alarco, and M. Raymond. 1997. The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter. J. Bacteriol. 179:7210-7218.
3. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
4. Bedell, G. W., and D. R. Soll. 1979. Effects of low concentrations of zinc on the growth and dimorphism of Candida albicans: evidence for zinc-resistant and zinc-sensitive pathways for mycelium formation. Infect. Immun. 26:348-354.
5. Blignaut, E., C. Pujol, S. Lockhart, S. Joly, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans isolates from human immunodeficiency virus-positive and healthy individuals reveals new clade in South Africa. J. Clin. Microbiol. 40:826-836.
6. Diekema, D. J., S. A. Messer, A. B. Brueggemann, S. L. Coffman, G. V. Doern, L. A. Herwaldt, and M. A. Pfaller. 2002. Epidemiology of candidemia: three-year results from the Emerging Infections and the Epidemiology of Iowa Organisms study. J. Clin. Microbiol. 40:1298-1302.
7. Hull, C. M., and A. D. Johnson. 1999. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science 285:1271-1275.
8. Hull, C. M., R. M. Raisner, and A. D. Johnson. 2000. Evidence for mating of the "asexual" yeast Candida albicans in a mammalian host. Science 289:307-310.
9. Kvaal, C., S. A. Lachke, T. Srikantha, K. Daniels, J. McCoy, and D. R. Soll. 1999. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect. Immun. 67:6652-6662.
10. Lan, C. Y., G. Newport, L. A. Murillo, T. Jones, S. Scherer, R. W. Davis, and N. Agabian. 2002. Metabolic specialization associated with phenotypic switching in Candida albicans. Proc. Natl. Acad. Sci. USA 99:14907-14912.
11. Lee, K. L., H. R. Buckley, and C. C. Campbell. 1975. An amino acid liquid synthetic medium for development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153.
12. Lockhart, S., C. Pujol, S. Joly, and D. R. Soll. 2001. Development and use of complex probes for DNA fingerprinting the infectious fungi. Med. Mycol. 39:1-8.
13. Lockhart, S., J. J. Fritch, A. S. Sturdevant Meier, K. Schroppel, T. Srikantha, R. Galask, and D. R. Soll. 1995. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J. Clin. Microbiol. 33:1501-1509.
14. Lockhart, S. R., C. Pujol, K. Daniels, M. Miller, A. D. Johnson, M. A. Pfaller, and D. R. Soll. 2002. In Candida albicans white-opaque switchers are homozygous for mating type. Genetics 162:737-745.
15. Lockhart, S. R., K. Daniels, R. Zhao, D. Wessels, and D. R. Soll. 2003. Cell biology of mating in Candida albicans. Eukaryot. Cell 2:49-61.
16. Magee, B. B., and P. T. Magee. 2000. Induction of mating in Candida albicans by construction of MTLa and MTLα strains. Science 289:310-313.
17. Miller, M. G., and A. D. Johnson. 2002. White-opaque switching in Candida albicans is controlled by mating-type locus homeodomain proteins and allows efficient mating. Cell 110:293-302.
18. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
19. Pfaller, M. A., and D. J. Diekema. 2002. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J. Clin. Microbiol. 40:3551-3557.
20. Pfaller, M. A., D. J. Diekema, R. N. Jones, S. A. Messer, R. J. Hollis, and the SENTRY Participant Group. 2002. Trends in antifungal susceptibility of Candida spp. from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000. J. Clin. Microbiol. 40:852-856.
21. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, H. Huynh, and R. J. Hollis. 2002. Clinical evaluation of a frozen commercially prepared microdilution panel for antifungal susceptibility testing of seven antifungal agents, including the new triazoles posaconazole, ravuconazole, and voriconazole. J. Clin. Microbiol. 40:1694-1697.
22. Pfaller, M. A., S. A. Messer, K. Mills, A. Bolmstrom, and R. N. Jones. 2001. Evaluation of E-test method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species. J. Clin. Microbiol. 39:4387-4389.
23. Pujol, C., M. Pfaller, and D. R. Soll. 2002. Ca3 fingerprinting of Candida albicans bloodstream isolates from the United States, Canada, South Africa, and Europe reveals a European clade. J. Clin. Microbiol. 40:2729-2740.
24. Pujol, C., S. Joly, B. Nolan, T. Srikantha, and D. R. Soll. 1999. Microevolutionary changes in Candida albicans identified by the complex Ca3 finger-printing probe involve insertions and deletions of the full-length repetitive sequence RPS at specific genomic sites. Microbiology 145:2635-2646.
25. Pujol, C., S. Joly, S. R. Lockhart, S. Noel, M. Tibayrenc, and D. R. Soll. 1997. Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans. J. Clin. Microbiol. 35:2348-2358.
26. Rikkerink, E. H. A., B. B. Magee, and P. T. Magee. 1988. Opaque-white phenotypic transition: a programmed morphological transition in Candida albicans. J. Bacteriol. 170:895-899.
27. Rustad, T. R., D. A. Stevens, M. A. Pfaller, and T. C. White. 2002. Homozygosity at the Candida albicans MTL locus associated with azole resistance. Microbiology. 148:1061-1072.
28. Sadhu, C., M. J. McEachern, E. P. Rustchenko-Bulgac, J. Schmid, D. R. Soll, and J. B. Hicks. 1991. Telomeric and dispersed repeat sequences in Candida yeasts and their use in strain identification. J. Bacteriol. 173:842-850.
29. Sanglard, D. 2002. Resistance of human fungal pathogens to antifungal drugs. Curr. Opin. Microbiol. 5:379-385.
30. Sanglard, D., and F. C. Odds. 2002. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect. Dis. 2:73-85.
31. Scherer, S., and D. A. Stevens. 1987. Application of DNA fingerprinting methods to epidemiology and taxonomy of Candida species. J. Clin. Microbiol. 25:675-679.
32. Schmid, J., E. Voss, and D. R. Soll. 1990. Computer-assisted methods for assessing strain relatedness in Candida albicans by fingerprinting with the moderately repetitive sequence Ca3. J. Clin. Microbiol. 28:1236-1243.
33. Slutsky, B., M. Staebell, J. Anderson, L. Risen, M. Pfaller, and D. R. Soll. 1987. "White-opaque transition": a second high-frequency switching system in Candida albicans. J. Bacteriol. 169:189-197.
34. Soll, D. R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13:332-370.
35. Soll, D. R. 2002. Candida commensalism and virulence: the evolution of phenotypic plasticity. Acta Trop. 81:101-110.
36. Soll, D. R. Candida albicans. In A. Craig and A. Scherf (ed.), Antigenic variation, in press. Academic Press, London, United Kingdom.
37. Srikantha, T., and D. R. Soll. 1993. A white-specific gene in the whiteopaque switching system of Candida albicans. Gene 131:53-60.
38. Vargas, K., S. A. Messer, M. Pfaller, S. R. Lockhart, J. T. Stapleton, J. Hellstein, and D. R. Soll. 2000. Elevated phenotypic switching and drug resistance of Candida albicans from human immunodeficiency virus-positive individuals prior to first thrush episode. J. Clin. Microbiol. 38:3595-3607.
39. White, T. C., K. A. Marr, and R. A. Bowden. 1998. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11:382-402.